Plasma growth hormone responses to constant infusions of human pancreatic growth hormone releasing factor. Intermittent secretion or response attenuation.

Administration of human pancreatic tumor growth hormone (GH) releasing factor (hpGRF[1-40]) as a single injection to normal human subjects stimulates the secretion of GH in a dose-responsive manner. In the present studies, hpGRF(1-40) was infused in a graded stepwise manner over a 6-h period in orde...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Webb, C B, Vance, M L, Thorner, M O, Perisutti, G, Thominet, J, Rivier, J, Vale, W, Frohman, L A
Médium: Artigo
Jazyk:Inglês
Vydáno: 1984
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC425189/
https://ncbi.nlm.nih.gov/pubmed/6429198
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky